Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
inflammatory5866 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A44859 | 27048892 | Best Pract Res Clin Gastroenterol | Dysbiosis in gastrointestinal disorders. | 2016 | Details |
| A44889 | 26955824 | Clin Chem | Thrombin Generation Assay and Its Application in the Clinical Laboratory. | 2016 | Details |
| A44894 | 26936934 | J Leukoc Biol | The role of macrophages in obesity-driven chronic liver disease. | 2016 | Details |
| A44900 | 26914713 | Cancer | Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis. | 2016 | Details |
| A44910 | 26858005 | Alcohol Clin Exp Res | Chronic Alcohol Consumption Causes Liver Injury in High-Fructose-Fed Male Mice Through Enhanced Hepatic Inflammatory Response. | 2016 | Details |
| A44934 | 26704864 | J Pediatr Gastroenterol Nutr | Plasminogen Activator Inhibitor-1 Predicts Quantity of Hepatic Steatosis Independent of Insulin Resistance and Body Weight. | 2016 | Details |
| A44936 | 26699087 | Hepatology | Histidine-rich glycoprotein promotes macrophage activation and inflammation in chronic liver disease. | 2016 | Details |
| A45004 | 26455261 | J Agric Food Chem | Gomisin J Inhibits Oleic Acid-Induced Hepatic Lipogenesis by Activation of the AMPK-Dependent Pathway and Inhibition of the Hepatokine Fetuin-A in HepG2 Cells. | 2015 | Details |
| A45020 | 26426833 | Eur J Gastroenterol Hepatol | Gallstones are associated with hidradenitis suppurativa: a population-based and hospital-based cross-sectional study from Denmark. | 2015 | Details |
| A45070 | 26179764 | Aliment Pharmacol Ther | Letter: TNFα inhibitors and prevalence of fatty liver disease in chronic inflammatory diseases. | 2015 | Details |
| A45098 | 26087059 | Clin Transl Gastroenterol | The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease. | 2015 | Details |
| A45115 | 26034866 | Am J Surg Pathol | Ipilimumab-associated Hepatitis: Clinicopathologic Characterization in a Series of 11 Cases. | 2015 | Details |
| A45144 | 25923946 | Eur J Gastroenterol Hepatol | Liver steatosis is a risk factor for hepatotoxicity in patients with inflammatory bowel disease under immunosuppressive treatment. | 2015 | Details |
| A45145 | 25922396 | Clin Infect Dis | New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. | 2015 | Details |
| A45161 | 25852814 | J Clin Aesthet Dermatol | Nonalcoholic Fatty liver disease and psoriasis: what a dermatologist needs to know. | 2015 | Details |
| A45169 | 25843660 | Nutr Metab Cardiovasc Dis | Iron status in obesity: An independent association with metabolic parameters and effect of weight loss. | 2015 | Details |
| A45174 | 25813056 | Am J Physiol Gastrointest Liver Physiol | Kupffer cell depletion protects against the steatosis, but not the liver damage, induced by marginal-copper, high-fructose diet in male rats. | 2015 | Details |
| A45193 | 25753820 | Hepatology | Obeticholic acid and resveratrol in nonalcoholic fatty liver disease: all that is gold does not glitter, not all those who wander are lost. | 2015 | Details |
| A45232 | 25588104 | J Interferon Cytokine Res | Fatty Acids Induce a Pro-Inflammatory Gene Expression Profile in Huh-7 Cells That Attenuates the Anti-HCV Action of Interferon. | 2015 | Details |
| A45254 | 25543233 | J Gastroenterol | Effect of PNPLA3 rs738409 variant (I148 M) on hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C. | 2014 | Details |
| A45278 | 25422106 | Diabetes | Hepatic cyclooxygenase-2 expression protects against diet-induced steatosis, obesity, and insulin resistance. | 2014 | Details |
| A45299 | 25295785 | Cell Metab | Periostin: a new extracellular regulator of obesity-induced hepatosteatosis. | 2014 | Details |
| A45307 | 25253983 | World J Gastroenterol | Is increased red cell distribution width an indicating marker of nonalcoholic steatohepatitis and fibrotic stage? | 2014 | Details |
| A45330 | 25148170 | AJR Am J Roentgenol | Accumulation of (18)F-FDG in the liver in hepatic steatosis. | 2014 | Details |
| A45345 | 25104498 | Am J Physiol Gastrointest Liver Physiol | Activation of N-methyl-d-aspartate receptor downregulates inflammasome activity and liver inflammation via a β-arrestin-2 pathway. | 2014 | Details |
| A45353 | 25073467 | Pharmacol Rev | Bile acid signaling in metabolic disease and drug therapy. | 2014 | Details |
| A45361 | 24993917 | J Nutr Biochem | Reversal of high-fat diet-induced hepatic steatosis by n-3 LCPUFA: role of PPAR-α and SREBP-1c. | 2014 | Details |
| A45368 | 24971027 | J Inflamm Res | Vitamin D and inflammatory diseases. | 2014 | Details |
| A45382 | 24895841 | Scand J Gastroenterol | National trends and inpatient outcomes of inflammatory bowel disease patients with concomitant chronic liver disease. | 2014 | Details |
| A45402 | 24790463 | Clin Cosmet Investig Dermatol | Psoriasis and comorbidities: links and risks. | 2014 | Details |
| A45415 | 24740831 | Mol Nutr Food Res | The molecular mechanisms underpinning the therapeutic properties of oleanolic acid, its isomer and derivatives for type 2 diabetes and associated complications. | 2014 | Details |
| A45419 | 24723444 | Hepatology | Helicobacter pylori might contribute to nonalcoholic fatty liver disease-related cardiovascular events by releasing prothrombotic and proinflammatory factors. | 2014 | Details |
| A45427 | 24680647 | Trends Immunol | The immunomodulating role of exercise in metabolic disease. | 2014 | Details |
| A45434 | 24629562 | Metabolism | Obesity-associated mechanisms of hepatocarcinogenesis. | 2014 | Details |
| A45449 | 24510391 | Dig Dis Sci | Prevalence and relevance of nonalcoholic fatty liver disease in patients with primary sclerosing cholangitis. | 2014 | Details |
| A45468 | 24398583 | Am J Phys Med Rehabil | Multiple factors predict physical performance in people with chronic liver disease. | 2014 | Details |
| A45487 | 24353344 | J Nutr | Antioxidant supplements reduced oxidative stress and stabilized liver function tests but did not reduce inflammation in a randomized controlled trial in obese children and adolescents. | 2013 | Details |
| A45501 | 24280056 | Endocrinology | Testosterone replacement ameliorates nonalcoholic fatty liver disease in castrated male rats. | 2013 | Details |
| A45508 | 24217034 | Ann Nutr Metab | Clinical consequences of diet-induced dysbiosis. | 2013 | Details |
| A45519 | 24183950 | Dig Liver Dis | Inflammatory hepatocellular adenomatosis, metabolic syndrome, polycystic ovary syndrome and non-alcoholic steatohepatitis: chance tetrad or association by necessity? | 2013 | Details |
| A45521 | 24170694 | Diabetes | ITCH deficiency protects from diet-induced obesity. | 2013 | Details |
| A45524 | 24143116 | Diabetes Metab Syndr Obes | Hepatic function and the cardiometabolic syndrome. | 2013 | Details |
| A45541 | 24026869 | Curr Diab Rep | What the genetics of lipodystrophy can teach us about insulin resistance and diabetes. | 2013 | Details |
| A45545 | 23999826 | Endocr Connect | Increased FGF21 plasma levels in humans with sepsis and SIRS. | 2013 | Details |
| A45547 | 23995473 | Diabetologia | Tipping the inflammatory balance: inflammasome activation distinguishes metabolically unhealthy from healthy obesity. | 2013 | Details |
| A45571 | 23840101 | Mediators Inflamm | Influence of gut microbiota on subclinical inflammation and insulin resistance. | 2013 | Details |
| A45597 | 23720735 | J Biol Chem | C/EBP homologous protein-induced macrophage apoptosis protects mice from steatohepatitis. | 2013 | Details |
| A45607 | 23698242 | Med Sci Sports Exerc | Exercise reduces inflammation and oxidative stress in obesity-related liver diseases. | 2013 | Details |
| A45609 | 23686813 | Hepatology | Adipose tissue-derived stem cells as a regenerative therapy for a mouse steatohepatitis-induced cirrhosis model. | 2013 | Details |
| A45611 | 23680744 | Hosp Pract (1995) | Pleiotropic effects of thiazolidinediones: implications for the treatment of patients with type 2 diabetes mellitus. | 2013 | Details |
| A45621 | 23610585 | Hepat Mon | Probiotic as a novel treatment strategy against liver disease. | 2013 | Details |
| A45624 | 23591557 | Curr Opin Cardiol | Epicardial fat and vascular risk: a narrative review. | 2013 | Details |
| A45643 | 23486979 | J Nutr | Fatty liver accompanies an increase in lactobacillus species in the hind gut of C57BL/6 mice fed a high-fat diet. | 2013 | Details |
| A45645 | 23482364 | Georgian Med News | [Role of proapoptotic p-53 factor in pathogenesis of nonalcoholic hepatosteatosis]. | 2013 | Details |
| A45648 | 23471889 | Diabetes Metab Res Rev | Hepatic manifestations of metabolic syndrome. | 2013 | Details |
| A45650 | 23448493 | Curr Pharm Des | Endothelial dysfunction in morbid obesity. | 2013 | Details |
| A45651 | 23448486 | Curr Pharm Des | Role of adiponectin in the metabolic syndrome: current perspectives on its modulation as a treatment strategy. | 2013 | Details |
| A45653 | 26201617 | Hepatol Int | Angiogenesis: a phenomenon which aggravates chronic liver disease progression. | 2012 | Details |
| A45655 | 23438451 | Toxicol Appl Pharmacol | Proinflammatory adipokine leptin mediates disinfection byproduct bromodichloromethane-induced early steatohepatitic injury in obesity. | 2013 | Details |
| A45677 | 23316217 | PPAR Res | PPAR Could Contribute to the Pathogenesis of Hepatocellular Carcinoma. | 2012 | Details |
| A45679 | 23304111 | PPAR Res | Misregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity. | 2012 | Details |
| A45684 | 23295629 | Food Chem Toxicol | Protective effects of matrine against progression of high-fructose diet-induced steatohepatitis by enhancing antioxidant and anti-inflammatory defences involving Nrf2 translocation. | 2013 | Details |
| A45698 | 23236625 | Curr Opin Clin Nutr Metab Care | Bibliography. Micronutrients. Current world literature. | 2012 | Details |
| A45706 | 23175343 | Postepy Hig Med Dosw (Online) | [Role of sphingolipids in digestive system]. | 2012 | Details |
| A45713 | 23144998 | PLoS One | Type 2 diabetes associated changes in the plasma non-esterified fatty acids, oxylipins and endocannabinoids. | 2012 | Details |
| A45716 | 23126101 | Nihon Rinsho | [Extraintestinal complications of inflammatory bowel disease]. | 2012 | Details |
| A45720 | 23108300 | Dig Dis | Promotion of hepatocellular carcinoma by hepatitis C virus. | 2012 | Details |
| A45730 | 23034023 | N Engl J Med | Clinical problem-solving. An intricate interplay. | 2012 | Details |
| A45779 | 22801247 | J Investig Med | Effect of insulin versus triple oral therapy on the progression of hepatic steatosis in type 2 diabetes. | 2012 | Details |
| A45783 | 22764879 | Liver Int | Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection. | 2012 | Details |
| A45784 | 22763792 | Curr Gastroenterol Rep | Fighting fire with fire: is it time to use probiotics to manage pathogenic bacterial diseases? | 2012 | Details |
| A45792 | 22715101 | J Biol Chem | The ABCG5 ABCG8 sterol transporter opposes the development of fatty liver disease and loss of glycemic control independently of phytosterol accumulation. | 2012 | Details |
| A45794 | 22701308 | J Biomed Biotechnol | Think small: zebrafish as a model system of human pathology. | 2012 | Details |
| A45805 | 22648736 | J Cachexia Sarcopenia Muscle | Consilience in sarcopenia of cirrhosis. | 2012 | Details |
| A45821 | 22531045 | Drug Metab Dispos | In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties. | 2012 | Details |
| A45863 | 22330258 | Toxicology | Susceptibility to gold nanoparticle-induced hepatotoxicity is enhanced in a mouse model of nonalcoholic steatohepatitis. | 2012 | Details |
| A45867 | 22295144 | Int J Clin Exp Pathol | Protective effect of xanthohumol on toxin-induced liver inflammation and fibrosis. | 2012 | Details |
| A45912 | 22122483 | Curr Pharm Biotechnol | Intestinal MicrobiOMICS to define health and disease in human and mice. | 2012 | Details |
| A45916 | 22095841 | Hepatology | Endoplasmic reticulum-tethered transcription factor cAMP responsive element-binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in mice. | 2012 | Details |
| A45919 | 22089363 | South Med J | Physical activity benefits and risks on the gastrointestinal system. | 2011 | Details |
| A45929 | 22005190 | Adv Cardiol | Metabolic disorders associated with obstructive sleep apnea in adults. | 2011 | Details |
| A45945 | 21911903 | Ann Hepatol | Citrus auraptene: a potential multifunctional therapeutic agent for nonalcoholic fatty liver disease. | 2011 | Details |
| A45953 | 21886053 | South Med J | A paradigm shift in the outpatient approach to liver function tests. | 2011 | Details |
| A45962 | 21819679 | Comp Med | The effects of diet composition on body fat and hepatic steatosis in an animal (Peromyscus californicus) model of the metabolic syndrome. | 2011 | Details |
| A45965 | 21807932 | JPEN J Parenter Enteral Nutr | Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. | 2011 | Details |
| A45994 | 21701901 | Hepatol Int | Murine gamma herpes virus 68 infection promotes fatty liver formation and hepatic insulin resistance in C57BL/6J mice. | 2011 | Details |
| A46032 | 21476910 | Expert Rev Gastroenterol Hepatol | Relevance of TNF-α gene polymorphisms in nonalcoholic fatty liver disease. | 2011 | Details |
| A46060 | 21364038 | Ann Pharmacother | Probable ketoprofen-associated nonalcoholic fatty liver disease and steatohepatitis. | 2011 | Details |
| A46069 | 21286336 | Hepatol Int | The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases. | 2010 | Details |
| A46108 | 21051057 | Med Clin (Barc) | [Association of hyperhomocysteinemia with liver steatosis in patients with chronic hepatitis C]. | 2010 | Details |
| A46111 | 21038411 | Hepatology | Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins. | 2010 | Details |
| A46117 | 20967760 | Hepatology | Disruption of the 12/15-lipoxygenase gene (Alox15) protects hyperlipidemic mice from nonalcoholic fatty liver disease. | 2010 | Details |
| A46191 | 20454765 | ScientificWorldJournal | Resolution of adipose tissue inflammation. | 2010 | Details |
| A46196 | 20423314 | Curr Med Chem | Pathophysiological role of pigment epithelium-derived factor (PEDF) in hepatic disorders. | 2010 | Details |
| A46198 | 20415823 | Dermatol Ther | Psoriasis, the liver, and the gastrointestinal tract. | 2010 | Details |
| A46210 | 20370675 | Curr Pharm Des | Adiponectin: a key player in obesity related disorders. | 2010 | Details |
| A46221 | 20211973 | Endocrinology | Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet. | 2010 | Details |
| A46223 | 20207831 | Endocrinology | A maternal "junk food" diet in pregnancy and lactation promotes nonalcoholic Fatty liver disease in rat offspring. | 2010 | Details |
| A46227 | 20185740 | Diabetes Care | Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet. | 2010 | Details |
| A46252 | 20008062 | J Pharmacol Exp Ther | A silybin-phospholipid complex prevents mitochondrial dysfunction in a rodent model of nonalcoholic steatohepatitis. | 2009 | Details |